Researchers have been excited about the medication , a groundbreaking dual agonist showing promising results in initial trials for body loss . It acts by modulating several hormones : GLP-1 and GIP, https://imogenbpkr741057.tusblogos.com/41393170/this-new-prospect-for-size-reduction